|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Advance to suppliers | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Financial assets at fair value through profit or loss | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Retention receivables | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Investment | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Intangible asset, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Digital assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Other payables and accrued liabilities | ||||||||||||||||||||
| Advance receipts | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Dividend payable | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Financial lease liabilities - current | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Long-term secured other borrowing – current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Long-term secured other borrowing | ||||||||||||||||||||
| Financial Liability at FVTPL | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Convertible preferred stock ($0.001 par value; Series B Preferred Stock, 1,000,000 shares authorized, 3,500 shares issued and outstanding as of December 31, 2025) | ||||||||||||||||||||
| Mezzanine equity | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Total mezzanine equity | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock ($0.001 par value; authorized 200,000,000 shares; 1,560,210 shares and 481,121 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively, as adjusted for the 1-for-30 reverse stock split effected on July 6, 2026; see Note 21) | ||||||||||||||||||||
| Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 shares authorized, 80,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Statutory and other reserves | ||||||||||||||||||||
| Accumulated losses | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total Nocera, Inc.’s stockholders’ equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity, and equity | ||||||||||||||||||||
Loading...